
浏览全部资源
扫码关注微信
海南省妇女儿童医学中心生殖医学中心
纸质出版日期:2023,
扫 描 看 全 文
马宁, 周知, 周璟, 等. 自体血小板富集血浆联合粒细胞集落刺激因子宫腔灌注对反复着床失败患者子宫内膜容受性及临床结局的影响[J]. 中国医院用药评价与分析, 2023,(2):158-161.
MA Ning, ZHOU Zhi, ZHOU Jing, et al. Effects of Autologous Platelet-Rich Plasma Combined with Granulocyte Colony-Stimulating Factor for Intrauterine Perfusion on Endometrial Receptivity and Clinical Outcome in Patients with Repeated Implantation Failure[J]. 2023,(2):158-161.
马宁, 周知, 周璟, 等. 自体血小板富集血浆联合粒细胞集落刺激因子宫腔灌注对反复着床失败患者子宫内膜容受性及临床结局的影响[J]. 中国医院用药评价与分析, 2023,(2):158-161. DOI: 10.14009/j.issn.1672-2124.2023.02.006.
MA Ning, ZHOU Zhi, ZHOU Jing, et al. Effects of Autologous Platelet-Rich Plasma Combined with Granulocyte Colony-Stimulating Factor for Intrauterine Perfusion on Endometrial Receptivity and Clinical Outcome in Patients with Repeated Implantation Failure[J]. 2023,(2):158-161. DOI: 10.14009/j.issn.1672-2124.2023.02.006.
目的:探讨自体血小板富集血浆(PRP)联合粒细胞集落刺激因子(G-CSF)宫腔灌注对反复着床失败(RIF)患者子宫内膜容受性(ER)及临床结局的影响。方法:选择2020年1月至2022年7月该院收治的RIF患者76例,按照冻融胚胎移植前是否进行宫腔灌注,分为PRP+G-CSF灌注组(n=38)和对照组(未灌注,n=38)。记录两组患者的胚胎种植率、化学妊娠率、临床妊娠率、早期流产率和异位妊娠率,比较胚胎移植日两组患者的子宫内膜厚度、形态、内膜血流类型以及血流动力学指标[子宫动脉搏动指数(PI)、阻力指数(RI)]
并记录PRP+G-CSF组患者宫腔灌注不良事件的发生情况。结果:治疗后,PRP+G-CSF组患者的胚胎种植率、化学妊娠率和临床妊娠率分别为46.88%(30/38)、60.53%(23/38)和60.53%(23/38)
高于对照组的26.56%(17/38)、31.58%(12/38)和31.58%(12/38)
差异均有统计学意义(P<0.05)。两组患者的早期流产率分别为4.35%(1/23)、16.67%(2/12)
差异无统计学意义(P>0.05)。两组患者均无异位妊娠发生,且PRP+G-CSF组患者无宫腔灌注不良事件发生。胚胎移植日,PRP+G-CSF组患者的子宫内膜厚度为(10.20±2.02) mm
较对照组的(9.15±1.51) mm增厚,差异有统计学意义(P<0.05);子宫内膜血流类型GⅡ型及以上占比、C型内膜占比为86.84%(33/38)、89.47%(34/38)
均高于对照组的65.79%(25/38)、71.05%(27/38)
差异均有统计学意义(P<0.05)。胚胎移植日,PRP+G-CSF组患者的子宫动脉PI和RI分别为2.35±0.53和0.83±0.08
均低于对照组的2.69±0.49和0.87±0.09
差异均有统计学意义(P<0.05)。结论:PRP联合G-CSF宫腔灌注能改善RIF患者子宫内膜厚度、血流灌注情况,进而改善其ER及妊娠结局。
OBJECTIVE: To probe into the effects of autologous platelet-rich plasma(PRP) combined with granulocyte colony-stimulating factor(G-CSF) for intrauterine perfusion on endometrial receptivity(ER) and clinical outcome in patients with repeated implantation failure(RIF). METHODS: Totally 76 patients with RIF admitted into this hospital from Jan. 2020 to Jul. 2022 were selected and divided into PRP+G-CSF perfusion group(38 cases) and control group(no perfusion
38 cases) according to whether or not intrauterine perfusion was performed before frozen-thawed embryo transfer. The embryo implantation rates
chemical pregnancy rates
clinical pregnancy rates
early miscarriage rates and ectopic pregnancy rates of both groups were recorded
the thickness
morphology
blood flow type and hemodynamic indexes [uterine artery pulsatility index(PI)
resistance index(RI)] of endometrium were compared between two groups on the day of embryo transfer
and the incidence of adverse events of uterine perfusion in the PRP+G-CSF group was recorded. RESULTS: After treatment
the embryo implantation rate
chemical pregnancy rate and clinical pregnancy rate of the PRP+G-CSF group were respectively 46.88%(30/38)
60.53%(23/38) and 60.53%(23/38)
which were higher than those of the control group [26.56%(17/38)
31.58%(12/38) and 31.58%(12/38)]
with statistically significant differences(P<0.05). The early abortion rates were 4.35%(1/23) and 16.67%(2/12) in the two groups
with no statistically significant difference(P>0.05). No ectopic pregnancy occurred in both groups
and there were no adverse events of intrauterine perfusion in the PRP+G-CSF group. On the day of embryo transfer
the endometrial thickness of patients in the PRP+G-CSF group was(10.20±2.02) mm
which was thicker than that of the control group [(9.15±1.51) mm]
with statistically significant difference(P<0.05); the percentage of endometrial blood flow type GⅡ or above and the percentage of C-type endometrium were respectively 86.84%(33/38) and 89.47%(34/38)
which were higher than those in the control group [65.79%(25/38) and 71.05%(27/38)]
with statistically significant differences(P<0.05). On the day of embryo transfer
the uterine artery PI and RI levels of patients in the PRP+G-CSF group were 2.35±0.53 and 0.83±0.08
which were lower than those of the control group(2.69±0.49 and 0.87±0.09)
with statistically significant differences(P<0.05). CONCLUSIONS: PRP combined with G-CSF intrauterine perfusion can improve endometrial thickness and blood perfusion in patients with RIF
thus improve their ER and pregnancy outcomes.
自体血小板富集血浆粒细胞集落刺激因子宫腔灌注反复着床失败子宫内膜容受性临床结局
Autologous platelet-rich plasmaGranulocyte colony-stimulating factorIntrauterine perfusionRepeated implantation failureEndometrial receptivityClinical outcome
0
浏览量
41
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621